Materiały źródłowe

• #1 Peripheral nerve tumors – Symptoms and causes – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/peripheral-nerve-tumors/symptoms-causes/syc-20355070

  Peripheral nerve tumors are growths that form in or near nerves. […] It’s not clear why most peripheral nerve tumors develop. Some are linked to known inherited syndromes, such as neurofibromatosis (types 1 and 2) and schwannomatosis. […] Others may be caused by changes in a gene.

• #2 Benign peripheral nerve tumor | Beacon Health System

  https://www.beaconhealthsystem.org/library/diseases-and-conditions/benign-peripheral-nerve-tumor?content_id=CON-20341913

  Several different types of tumors may form on the peripheral nerves. While some are caused by genetics, the cause of these tumors is usually not known. […] The cause of benign peripheral nerve tumors usually isn’t known. Some are passed down in families. […] For neurofibromas, having the genetic condition known as neurofibromatosis type 1 (NF1) is a risk factor. NF1 can cause someone to have several neurofibromas. But most people who have neurofibromas don’t have NF1. […] For schwannomas, having the gene that causes schwannomatosis is a risk factor.

• #3 Peripheral nerve tumors – Augusta HealthSearchClose SearchSearch IconSearch IconClose Search IconMobile Menu IconMobile Menu Close IconInstagramFacebookTwitterYoutube

  https://www.augustahealth.com/disease/peripheral-nerve-tumors/

  It’s not clear why most peripheral nerve tumors develop. Some are linked to known inherited syndromes, such as neurofibromatosis (types 1 and 2) and schwannomatosis. Others may be caused by a malfunctioning gene or triggered by injury or surgery. […] Peripheral nerve tumors are more common in people who have: […] Neurofibromatosis (types 1 and 2) and schwannomatosis. In these disorders, tumors develop on or near the nerves throughout the body. These tumors, which are frequently multiple, can lead to a variety of symptoms and signs depending on their location. These tumors are usually noncancerous. […] A history of radiation treatment. If you were exposed to radiation, you are at increased risk of peripheral nerve tumors years later.

• #4 Nerve Sheath Tumors: Definition & Types

  https://my.clevelandclinic.org/health/diseases/22526-nerve-sheath-tumors

  Genetic changes play an important role in the development of nerve sheath tumors. Alteration of the NF2 gene is linked to schwannomas, while the NF1 gene is associated with neurofibromas. […] Most often, these genetic changes are sporadic and happen randomly. A small fraction of schwannomas and neurofibromas are caused by a rare, genetic disease that runs in families called neurofibromatosis. […] The types of neurofibromatosis are: Neurofibromatosis type 1 (NF1): People with NF1 have multiple neurofibromas. They might also develop plexiform neuromas and are at higher risk of malignant peripheral nerve sheath tumors. […] Neurofibromatosis type 2 (NF2): Nearly all people with NF2 develop vestibular schwannomas in both ears before age 30. […] Malignant peripheral nerve sheath tumors have a poor prognosis, especially if the tumor is larger than 2 inches. Fewer than half of people with this condition live five years after diagnosis.

• #5 Peripheral Nerve Sheath Tumors | Neurological Surgery

  https://neurosurgery.weillcornell.org/condition/peripheral-nerve-sheath-tumors

  Peripheral nerves are bundles of fibers wrapped in layers of a fatty, insulating material called myelin and connective tissue. Together these layers are known as the nerve sheath, and they can develop tumors. […] Individuals may be predisposed to developing peripheral nerve sheath tumors if they have a family history of them. Even in those without a family history, these tumors can form due to certain genetic mutations that result in an overactivation of nerve sheath cells. Those who have had radiation therapy to treat cancer may be at risk for MPNSTs between 10 and 20 years after treatment.

• #6 Pathology Outlines – Malignant peripheral nerve sheath tumor (MPNST)

  https://www.pathologyoutlines.com/topic/softtissuempnst.html

  Malignant neoplasm arising from peripheral nerve […] May arise from a preexisting nerve sheath tumor in neurofibromatosis type 1 (NF1) or in the setting of prior radiation therapy […] In the absence of association with NF1 or radiation, diagnosis is challenging and based on histologic and immunohistochemical features suggesting Schwannian differentiation (Am J Surg Pathol 2016;40:896) […] MPNST can occur in the following settings: […] Sporadic (approximately 50%) […] In neurofibromatosis type 1 (40 – 50%) […] In the setting of prior radiation therapy (10%) […] Germline mutations in NF1 predispose to the development of peripheral nerve sheath neoplasms in patients with type 1 neurofibromatosis (Acta Neuropathol 2012;123:349) […] In the setting of NF1, lesions often arise from plexiform neurofibroma (Acta Neuropathol 2012;123:349)

• #7 What Are Malignant Peripheral Nerve Sheath Tumors?

  https://www.rwjbh.org/treatment-care/neuroscience/neurology/conditions/malignant-peripheral-nerve-sheath-tumors/

  Malignant peripheral nerve sheath tumors, also known as neurofibrosarcomas, are found in the protective lining, or myelin sheath, surrounding the peripheral (outside) nerves of the spinal cord the nerves that reach out to the rest of the body. These rare cancerous tumors occur most commonly in the muscle, fat, nerves, and other soft tissue of the torso, arms, or legs. […] The exact causes of these tumors arent known, but they begin when a cell in the sheath develops a DNA mutation. They grow and divide much faster than normal. The excess of cells forms invasive, spreadable tumors. […] Malignant peripheral nerve sheath tumors are most common in young adults and middle-aged adults, and more than half are found in people who have neurofibromatosis 1 (a non-cancerous condition that causes bone deformities).

• #8 Nerve Sheath Tumors: Definition & Types

  https://my.clevelandclinic.org/health/diseases/22526-nerve-sheath-tumors

  Genetic changes play an important role in the development of nerve sheath tumors. Alteration of the NF2 gene is linked to schwannomas, while the NF1 gene is associated with neurofibromas. […] Most often, these genetic changes are sporadic and happen randomly. A small fraction of schwannomas and neurofibromas are caused by a rare, genetic disease that runs in families called neurofibromatosis. […] The types of neurofibromatosis are: Neurofibromatosis type 1 (NF1): People with NF1 have multiple neurofibromas. They might also develop plexiform neuromas and are at higher risk of malignant peripheral nerve sheath tumors. […] Neurofibromatosis type 2 (NF2): Nearly all people with NF2 develop vestibular schwannomas in both ears before age 30. […] Malignant peripheral nerve sheath tumors have a poor prognosis, especially if the tumor is larger than 2 inches. Fewer than half of people with this condition live five years after diagnosis.

• #9 Nerve Tumors | Brain Institute | OHSU

  https://www.ohsu.edu/brain-institute/nerve-tumors

  Nerve tumors are abnormal masses that grow on or in peripheral nerves, the nerves that branch from the brain and spinal cord through the rest of the body. […] Most of the time, nerve tumors are not linked to any risk factor or known cause. Known risk factors include: […] Each type is linked to a different genetic defect. These defects can be inherited (passed down in families), or spontaneous (arising for unknown reasons). […] Neurofibromatosis 1: This is the most common neurofibromatosis disorder, affecting up to about one in 3,000 Americans. Its also known as NF1. It has a range of symptoms, including tumors that range from small nodules to large lumps. Most are benign tumors called neurofibromas. […] Neurofibromatosis 2: This type, also called NF2, is linked to slow-growing nerve tumors called schwannomas. Schwannomas develop from the Schwann cells that form nerve sheaths. Most people with NF2 develop vestibular schwannomas tumors on the vestibular nerves that link each inner ear to the brain by age 30. […] Each type is linked to a different genetic defect. These defects can be inherited (passed down in families), or spontaneous (arising for unknown reasons).

• #10

  https://braintumourresearch.org/pages/types-of-brain-tumours-schwannoma?srsltid=AfmBOopcYQlWqRT6L9puA7gHNNkH9WhzT-A2bYiuF1jHugC6XbblN_nT

  Most schwannomas occur spontaneously. The cause of a schwannoma brain tumour is, in the majority of cases, the development of fault in a gene called NF2 (which is a gene on chromosome 22 in our DNA). […] The NF2 gene provides instructions for the body to make a protein called merlin. This protein is also known as schwannomin because it is produced in schwann cells within the nervous system. The merlin protein acts as a tumour suppressor. In other words, it prevents cells from growing and dividing in an uncontrolled way. When it fails to carry out this function, tumours form from the schwann cells that surround the nerves. […] Researchers also suspect that merlin helps to control cell movement, cell shape and communication between cells. The NF2 fault can lead to the genetic disease called neurofibromatosis 2.

• #11 Schwannoma – Symptoms, Causes, TreatmentsSecond Opinion IconGroup 9Group 49

  https://www.barrowneuro.org/condition/schwannoma/

  Schwannomas only occur on the nerves of the peripheral nervous system, outside of the brain and spinal cord. […] The exact cause of schwannomas is not fully understood. They can sometimes be associated with genetic conditions called neurofibromatosis type 2 (NF2) and schwannomatosis. […] Schwannomas are rare, with less than 200,000 diagnosed cases yearly in the United States. However, they are the most common tumors of peripheral nerves in adults. […] Schwannomas can occur at any age but are most commonly diagnosed in adults between 20 and 50. They are slightly more common in women than in men. […] Schwannoma can occur in people of all ages. However, they are more common in people with the genetic disorders neurofibromatosis type 2 (NF2) and schwannomatosis. […] These tumors are often associated with genetic conditions, such as neurofibromatosis type 1 (NF1), which significantly increases the risk of developing MPNSTs.

• #12

  https://braintumourresearch.org/pages/types-of-brain-tumours-schwannoma?srsltid=AfmBOopcYQlWqRT6L9puA7gHNNkH9WhzT-A2bYiuF1jHugC6XbblN_nT

  Most schwannomas occur spontaneously. The cause of a schwannoma brain tumour is, in the majority of cases, the development of fault in a gene called NF2 (which is a gene on chromosome 22 in our DNA). […] The NF2 gene provides instructions for the body to make a protein called merlin. This protein is also known as schwannomin because it is produced in schwann cells within the nervous system. The merlin protein acts as a tumour suppressor. In other words, it prevents cells from growing and dividing in an uncontrolled way. When it fails to carry out this function, tumours form from the schwann cells that surround the nerves. […] Researchers also suspect that merlin helps to control cell movement, cell shape and communication between cells. The NF2 fault can lead to the genetic disease called neurofibromatosis 2.

• #13

  https://journals.lww.com/jpat/fulltext/2022/26040/an_update_on_oral_peripheral_nerve_sheath_tumors.20.aspx

  Bispecific allelic loss of NF (one hit from the germline and other acquired somatically) resulting in RAS activation is directly assumed to responsible for development of neuro-fibromas. […] Neurofibroma occurs due to nonmyelinating p75+ Schwann cell progenitors which are the major cell for NF 1 loss. […] The RAS/RAF genes are the proto-oncogenes characterized by signal transduction in cell biology. […] Aberrant change in pathways due to genetic or epigenetic alteration is a common cause of cell transformation, cancer development and metastasis, and RTKs play critical roles in development/regulation stemness and proliferation. […] The AKT/mTOR pathways play important roles in modulating cellular functions in response to extracellular signals, such as growth factors and cytokines.

• #14 Malignant Peripheral Nerve Sheath Tumour – SFA

  https://curesarcoma.org/sarcoma-subtypes/malignant-peripheral-nerve-sheath-tumour/

  Malignant peripheral nerve sheath tumor (MPNST) is a malignant spindle cell tumor often arising from a peripheral nerve, from a pre-existing benign nerve sheath tumor, or in a patient with neurofibromatosis type 1 (NF1). […] MPNST may be associated with irradiation or NF1. […] Despite different clinical presentations (e.g., NF1-associated, sporadic de novo, or radiotherapy-associated), recent genomic studies of MPNSTs demonstrated highly frequent and concurrent inactivating mutations in three pathways: NF1, CDKN2A/CDKN2B, and PRC2 core components (EED or SUZ12), resulting in complete loss of function. […] In NF1-associated peripheral nerve sheath tumors, as benign precursor plexiform neurofibroma progresses into atypical neurofibroma / atypical neurofibromatous neoplasm of uncertain biological potential and/or transforms to high-grade MPNST, it is accompanied by progressive genomic alterations that inactivate the neurofibromin (NF1), p16/p15 (CDKN2A/CDKN2B), and PRC2 pathways and increased genomic copy-number variations, respectively.

• #15 Pathology Outlines – Malignant peripheral nerve sheath tumor (MPNST)

  https://www.pathologyoutlines.com/topic/softtissuempnst.html

  Transformation process is accompanied by progressive genomic changes involving NF1, CDKN2A / CDKN2B and PRC2 (Hum Pathol 2017;67:1) […] Radiation therapy predisposes to the development of secondary sarcomas through repeated DNA damage and defective repair […] Other nerve sheath tumors (schwannoma, ganglioneuroma) may rarely give rise to secondary MPNST (Am J Surg Pathol 1994;18:882, Am J Surg Pathol 2001;25:13, Pathology 2015;47:595, Histopathology 1988;12:445) […] Plexiform neurofibroma is a common precursor lesion in patients with NF1 […] Patients with NF1 have an 8 – 13% lifetime risk of developing MPNST […] 10 – 15% of plexiform neurofibromas transform to MPNST (Hum Mutat 2008;29:E103) […] […] […] See Epidemiology

• #16 Mayo Clinic Health Library – Peripheral nerve tumors | Swiss Medical Network

  https://www.swissmedical.net/en/healtcare-library/con-20213617

  It’s not clear why most peripheral nerve tumors develop. Some are linked to known inherited syndromes, such as neurofibromatosis (types 1 and 2) and schwannomatosis. Others may be caused by changes in a gene. […] Peripheral nerve tumors are more common in people who have: […] Neurofibromatosis (types 1 and 2) and schwannomatosis. In these disorders, tumors develop on or near the nerves throughout the body. There are often multiple tumors. They can lead to a variety of symptoms depending on where they are in the body. These tumors are usually not cancerous. […] A history of radiation treatment. A person who was exposed to radiation is at higher risk of developing peripheral nerve tumors years later.

• #17 Peripheral nerve tumors | Health Library | Memorial Health System

  https://www.mhsystem.org/health-library/con-20213617/

  Peripheral nerve tumors can occur anywhere in the body. Most of them are benign, meaning theyre not cancerous. But they can lead to pain, nerve damage and loss of function in the affected area. […] Its not clear why most peripheral nerve tumors develop. Some are linked to known inherited syndromes, such as neurofibromatosis (types 1 and 2) and schwannomatosis. Others may be caused by changes in a gene. […] Peripheral nerve tumors are more common in people who have: Neurofibromatosis (types 1 and 2) and schwannomatosis. In these disorders, tumors develop on or near the nerves throughout the body. There are often multiple tumors. They can lead to a variety of symptoms depending on where they are in the body. These tumors are usually not cancerous. […] A person who was exposed to radiation is at higher risk of developing peripheral nerve tumors years later.

• #18 Malignant peripheral nerve sheath tumors | Altru Health System

  https://www.altru.org/health-library/conditions/malignant-peripheral-nerve-sheath-tumors

  Malignant peripheral nerve sheath tumors are rare cancers that start in the lining of the nerves. […] It’s not clear what causes most malignant peripheral nerve sheath tumors. […] Experts know that these cancers begin when a cell in the lining around a nerve gets changes in its DNA. […] The changes tell the cells to make more cells quickly. […] These cells continue to live when healthy cells die as part of their life cycle. […] The cells then can form a mass called a tumor. […] Factors that increase the risk of malignant peripheral nerve sheath tumors include: […] A malignant peripheral nerve sheath tumor might occur in the area treated with radiation 10 to 20 years after treatment. […] Malignant peripheral nerve sheath tumors can develop from nerve tumors that aren’t cancerous, such as neurofibroma. […] Malignant peripheral nerve sheath tumors occur more often in people with neurofibromatosis 1.

• #19 Neurofibrosarcoma and Schwannoma

  https://www.webmd.com/cancer/neurofibrosarcoma-and-schwannoma

  Schwannomas are most often noncancerous nerve tumors, while neurofibrosarcomas are cancerous. Doctors dont know what causes either of them, although some cases may be connected to genetics. […] Doctors still dont understand what causes about 90% of schwannomas. Most schwannomas occur at random, but certain genetic conditions, such as neurofibromatosis type 2, can significantly increase the risk of developing schwannomas, Westbroek says. A related condition, neurofibromatosis type 1, is associated with a significantly increased risk of developing neurofibrosarcoma. […] As with schwannomas, researchers still have to find out what causes most neurofibrosarcomas. What we do know is that an inherited disorder known as neurofibromatosis type 1 (previously known as von Recklinghausen disease) is „associated with a significantly increased risk of developing neurofibrosarcoma, according to Westbroek. Radiation exposure is also associated with an increased risk of developing neurofibrosarcoma, he says.

• #20 Malignant Peripheral Nerve Sheath Tumors – Rein in Sarcoma

  https://www.reininsarcoma.org/mpnst/

  Another risk factor for MPNST is previous radiation therapy. While the prevalence of MPNSTs in the general population is only 0.001%, the risk of developing a MPNST as a secondary malignancy due to prior radiotherapy is 0.06%. A MPNST may develop in a radiation-treated area within 10-20 years of receiving treatment. This etiology is often linked with radiation treatment for childhood cancer. Up to 10% of MPNSTs are attributed to prior radiation treatment. […] Malignant transformation of a benign plexiform neurofibroma may first present as new, intensifying or persistent pain localized to the pre-existing mass.

• #21 Pathology Outlines – Malignant peripheral nerve sheath tumor (MPNST)

  https://www.pathologyoutlines.com/topic/softtissuempnst.html

  Transformation process is accompanied by progressive genomic changes involving NF1, CDKN2A / CDKN2B and PRC2 (Hum Pathol 2017;67:1) […] Radiation therapy predisposes to the development of secondary sarcomas through repeated DNA damage and defective repair […] Other nerve sheath tumors (schwannoma, ganglioneuroma) may rarely give rise to secondary MPNST (Am J Surg Pathol 1994;18:882, Am J Surg Pathol 2001;25:13, Pathology 2015;47:595, Histopathology 1988;12:445) […] Plexiform neurofibroma is a common precursor lesion in patients with NF1 […] Patients with NF1 have an 8 – 13% lifetime risk of developing MPNST […] 10 – 15% of plexiform neurofibromas transform to MPNST (Hum Mutat 2008;29:E103) […] […] […] See Epidemiology

• #22 Malignant peripheral nerve sheath tumors | Altru Health System

  https://www.altru.org/health-library/conditions/malignant-peripheral-nerve-sheath-tumors

  Malignant peripheral nerve sheath tumors are rare cancers that start in the lining of the nerves. […] It’s not clear what causes most malignant peripheral nerve sheath tumors. […] Experts know that these cancers begin when a cell in the lining around a nerve gets changes in its DNA. […] The changes tell the cells to make more cells quickly. […] These cells continue to live when healthy cells die as part of their life cycle. […] The cells then can form a mass called a tumor. […] Factors that increase the risk of malignant peripheral nerve sheath tumors include: […] A malignant peripheral nerve sheath tumor might occur in the area treated with radiation 10 to 20 years after treatment. […] Malignant peripheral nerve sheath tumors can develop from nerve tumors that aren’t cancerous, such as neurofibroma. […] Malignant peripheral nerve sheath tumors occur more often in people with neurofibromatosis 1.

• #23 Pathology Outlines – Malignant peripheral nerve sheath tumor (MPNST)

  https://www.pathologyoutlines.com/topic/softtissuempnst.html

  Transformation process is accompanied by progressive genomic changes involving NF1, CDKN2A / CDKN2B and PRC2 (Hum Pathol 2017;67:1) […] Radiation therapy predisposes to the development of secondary sarcomas through repeated DNA damage and defective repair […] Other nerve sheath tumors (schwannoma, ganglioneuroma) may rarely give rise to secondary MPNST (Am J Surg Pathol 1994;18:882, Am J Surg Pathol 2001;25:13, Pathology 2015;47:595, Histopathology 1988;12:445) […] Plexiform neurofibroma is a common precursor lesion in patients with NF1 […] Patients with NF1 have an 8 – 13% lifetime risk of developing MPNST […] 10 – 15% of plexiform neurofibromas transform to MPNST (Hum Mutat 2008;29:E103) […] […] […] See Epidemiology

• #24 Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management

  https://www.mdpi.com/2072-6694/15/4/1077

  Several studies over the last decade have indicated that NF1-associated MPNSTs typically begin as plexiform neurofibroma (PN) and atypical neurofibromatous neoplasm of unknown biological potential (ANNUBP). […] In summary, previous studies have found numerous risk factors associated with the onset of MPNST. NF1 is the most important factor in 50% of MPNST patients. The history of therapeutic irradiation can also increase the risk of MPSNT. Possession of PN and ANNUBP has malignant potential to cause MPNST development. Additionally, aging is an important risk factor because MPNST development takes a long time.

• #25 Pathology Outlines – Malignant peripheral nerve sheath tumor (MPNST)

  https://www.pathologyoutlines.com/topic/softtissuempnst.html

  Transformation process is accompanied by progressive genomic changes involving NF1, CDKN2A / CDKN2B and PRC2 (Hum Pathol 2017;67:1) […] Radiation therapy predisposes to the development of secondary sarcomas through repeated DNA damage and defective repair […] Other nerve sheath tumors (schwannoma, ganglioneuroma) may rarely give rise to secondary MPNST (Am J Surg Pathol 1994;18:882, Am J Surg Pathol 2001;25:13, Pathology 2015;47:595, Histopathology 1988;12:445) […] Plexiform neurofibroma is a common precursor lesion in patients with NF1 […] Patients with NF1 have an 8 – 13% lifetime risk of developing MPNST […] 10 – 15% of plexiform neurofibromas transform to MPNST (Hum Mutat 2008;29:E103) […] […] […] See Epidemiology

• #26 Malignant Peripheral Nerve Sheath Tumors – Rein in Sarcoma

  https://www.reininsarcoma.org/mpnst/

  Another risk factor for MPNST is previous radiation therapy. While the prevalence of MPNSTs in the general population is only 0.001%, the risk of developing a MPNST as a secondary malignancy due to prior radiotherapy is 0.06%. A MPNST may develop in a radiation-treated area within 10-20 years of receiving treatment. This etiology is often linked with radiation treatment for childhood cancer. Up to 10% of MPNSTs are attributed to prior radiation treatment. […] Malignant transformation of a benign plexiform neurofibroma may first present as new, intensifying or persistent pain localized to the pre-existing mass.

• #27 Peripheral Nerve Compression Laguna Niguel CA | Nerve Injury Irvine, Dana Point, Orange County

  https://www.drbhwang.com/peripheral-nerve-tumors-neurosurgeon-spine-brain-surgery-laguna-hills-irvine-san-clemente-ca/

  Peripheral nerve tumors are growths in or near the strands of nerves that transmit signals from your brain to the rest of your body. […] The exact causes of peripheral nerve tumors are unknown. Some of them are associated with inherited diseases like neurofibromatosis (types 1 and 2) and schwannomatosis. Others are brought on by a faulty gene or triggered by an injury or surgery.

• #28 Nerve Sheath Tumors | The National Canine Cancer Foundation

  https://wearethecure.org/learn-more-about-canine-cancer/canine-cancer-library/nerve-sheath-tumors/

  Peripheral nerve sheath tumors are those originating from the peripheral nervous system (it extends outside the central nervous system consisting of the brain and spinal cord, although these can also arise from cranial nerves and affect these structures). […] Although the etiology is unknown, they are believed to develop in areas around former injury. Normally schwan cells from which these tumors originate help in the restoration of tissues and cells damaged during injury. It is thought that during the process of repair, tumorogenesis takes place. However, there is no published information supporting the fact.

• #29 Nerve Sheath Tumors | The National Canine Cancer Foundation

  https://wearethecure.org/learn-more-about-canine-cancer/canine-cancer-library/nerve-sheath-tumors/

  Peripheral nerve sheath tumors are those originating from the peripheral nervous system (it extends outside the central nervous system consisting of the brain and spinal cord, although these can also arise from cranial nerves and affect these structures). […] Although the etiology is unknown, they are believed to develop in areas around former injury. Normally schwan cells from which these tumors originate help in the restoration of tissues and cells damaged during injury. It is thought that during the process of repair, tumorogenesis takes place. However, there is no published information supporting the fact.

• #30 Peripheral nerve tumors – Augusta HealthSearchClose SearchSearch IconSearch IconClose Search IconMobile Menu IconMobile Menu Close IconInstagramFacebookTwitterYoutube

  https://www.augustahealth.com/disease/peripheral-nerve-tumors/

  It’s not clear why most peripheral nerve tumors develop. Some are linked to known inherited syndromes, such as neurofibromatosis (types 1 and 2) and schwannomatosis. Others may be caused by a malfunctioning gene or triggered by injury or surgery. […] Peripheral nerve tumors are more common in people who have: […] Neurofibromatosis (types 1 and 2) and schwannomatosis. In these disorders, tumors develop on or near the nerves throughout the body. These tumors, which are frequently multiple, can lead to a variety of symptoms and signs depending on their location. These tumors are usually noncancerous. […] A history of radiation treatment. If you were exposed to radiation, you are at increased risk of peripheral nerve tumors years later.

• #31

  https://continentalhospitals.com/diseases/benign-peripheral-nerve-tumor/

  Benign peripheral nerve tumors, also known as neurofibromas, are non-cancerous growths that develop on the peripheral nerves throughout the body. These tumors arise from the cells that make up the protective covering of the nerves called Schwann cells. Neurofibromas can occur in individuals with a condition called neurofibromatosis, which is a genetic disorder characterized by the growth of multiple tumors along the nervous system. However, they can also develop sporadically in people without any underlying genetic predisposition. […] Understanding the causes of a benign peripheral nerve tumor is crucial in order to effectively diagnose and treat this condition. While the exact cause of these tumors is not always clear, there are several factors that have been identified as potential contributors. One potential cause of benign peripheral nerve tumors is genetic mutations. Certain genetic conditions, such as neurofibromatosis type 1 (NF1) and schwannomatosis, have been linked to an increased risk of developing these tumors. These conditions result in abnormalities in the genes responsible for regulating cell growth and division within the peripheral nerves. Additionally, exposure to certain environmental factors may play a role in the development of benign peripheral nerve tumors. For example, individuals who have been exposed to certain chemicals or toxins, such as vinyl chloride or arsenic, may be at an increased risk. Furthermore, it is important to note that while these factors may contribute to the development of benign peripheral nerve tumors, they do not guarantee their occurrence. Many individuals with these risk factors never develop tumors, highlighting the complex nature of this condition.

• #32

  https://continentalhospitals.com/diseases/benign-peripheral-nerve-tumor/

  Benign peripheral nerve tumors, also known as neurofibromas, are non-cancerous growths that develop on the peripheral nerves throughout the body. These tumors arise from the cells that make up the protective covering of the nerves called Schwann cells. Neurofibromas can occur in individuals with a condition called neurofibromatosis, which is a genetic disorder characterized by the growth of multiple tumors along the nervous system. However, they can also develop sporadically in people without any underlying genetic predisposition. […] Understanding the causes of a benign peripheral nerve tumor is crucial in order to effectively diagnose and treat this condition. While the exact cause of these tumors is not always clear, there are several factors that have been identified as potential contributors. One potential cause of benign peripheral nerve tumors is genetic mutations. Certain genetic conditions, such as neurofibromatosis type 1 (NF1) and schwannomatosis, have been linked to an increased risk of developing these tumors. These conditions result in abnormalities in the genes responsible for regulating cell growth and division within the peripheral nerves. Additionally, exposure to certain environmental factors may play a role in the development of benign peripheral nerve tumors. For example, individuals who have been exposed to certain chemicals or toxins, such as vinyl chloride or arsenic, may be at an increased risk. Furthermore, it is important to note that while these factors may contribute to the development of benign peripheral nerve tumors, they do not guarantee their occurrence. Many individuals with these risk factors never develop tumors, highlighting the complex nature of this condition.

• #33

  https://continentalhospitals.com/diseases/benign-peripheral-nerve-tumor/

  One of the primary risk factors for benign peripheral nerve tumors is a genetic predisposition. Research suggests that certain inherited conditions, such as neurofibromatosis type 1 and schwannomatosis, can significantly increase the chances of developing these tumors. Individuals with a family history of these conditions should be particularly vigilant in monitoring their health. Another potential risk factor is exposure to certain environmental toxins or radiation. Studies have indicated a possible link between occupational exposure to chemicals or radiation and the development of benign peripheral nerve tumors. It is important for individuals working in industries where such exposures are common to take appropriate precautions and follow safety guidelines. Age can also play a role in determining the risk of developing these tumors. While they can occur at any age, they are more commonly observed in adults between the ages of 30 and 60. Regular medical check-ups and screenings become increasingly important as individuals reach this age range. It is worth noting that while these risk factors may increase the likelihood of developing benign peripheral nerve tumors, they do not guarantee their occurrence. Many cases occur sporadically without any identifiable cause or predisposing factors. By understanding these risk factors, individuals can take proactive steps towards early detection, proper diagnosis, and timely treatment if necessary. Regular communication with healthcare professionals can provide valuable guidance on managing individual risks and maintaining overall well-being.

• #34 Peripheral nerve damage (peripheral neuropathy) | Canadian Cancer Society

  https://cancer.ca/en/treatments/side-effects/peripheral-nerve-damage

  Peripheral nerve damage can be caused by: […] a tumour growing into or pressing on a peripheral nerve […] You may have a higher risk of developing peripheral neuropathy if you have: […] a history of exposure to pesticides or heavy metals (for example, lead, mercury)

• #35 Nervous system: Peripheral nerve sheath tumors

  https://atlasgeneticsoncology.org/solid-tumor/5094/nervous-system-peripheral-nerve-sheath-tumors

  The etiology of PNSTs is usually unknown. However, several hereditary disorders are known to predispose to benign and malignant PNSTs, notably neurofibromatosis type 1 (NF1) and neurofibromatosis type 2 (NF2), both of which are inherited in an autosomal dominant fashion. […] The basis for MPNST occurring in the setting of NF1 is presumed to be biallelic inactivation of the NF1 gene. Indeed, allelic imbalance at the NF1 locus in 17q is commonly (20-50% of the cases) detected in sporadic as well as NF1-associated MPNSTs.

• #36 Peripheral Nerve Tumors of the Extremities | Neupsy Key

  https://neupsykey.com/peripheral-nerve-tumors-of-the-extremities/

  Mutations in the NF2 gene at the 22q12.2 locus are found in sporadic schwannomas and those in patients with NF2. The schwannomas that develop in patients with schwannomatosis show a multitude of truncations in the NF2 gene, and multiple tumors from an individual patient can each have unique mutations.

• #37

  https://braintumourresearch.org/pages/types-of-brain-tumours-schwannoma?srsltid=AfmBOopcYQlWqRT6L9puA7gHNNkH9WhzT-A2bYiuF1jHugC6XbblN_nT

  Most schwannomas occur spontaneously. The cause of a schwannoma brain tumour is, in the majority of cases, the development of fault in a gene called NF2 (which is a gene on chromosome 22 in our DNA). […] The NF2 gene provides instructions for the body to make a protein called merlin. This protein is also known as schwannomin because it is produced in schwann cells within the nervous system. The merlin protein acts as a tumour suppressor. In other words, it prevents cells from growing and dividing in an uncontrolled way. When it fails to carry out this function, tumours form from the schwann cells that surround the nerves. […] Researchers also suspect that merlin helps to control cell movement, cell shape and communication between cells. The NF2 fault can lead to the genetic disease called neurofibromatosis 2.

• #38

  https://journals.lww.com/jpat/fulltext/2022/26040/an_update_on_oral_peripheral_nerve_sheath_tumors.20.aspx

  Peripheral nerve sheath tumors (PNSTs) are defined as type of sarcomas that develops in cells which forms a protective sheath (covering) around the peripheral nerve, i.e., the cells of myelin sheath. […] Nerve tumors are of neuroectodermal in origin as it composed of small rounded ectodermal cells that mostly affect soft tissues. […] About 70% of nerve tumor occurrence is sporadic, but people with an inherited condition such as neurofibromatosis 1 and 2 and schwannomatosis (20%) have an increased risk of developing nerve sheath tumors. […] The majority of neurofibromas (90%) are sporadic and are caused by biallelic (double hit) inactivation of NF 1 gene on chromosomes 17q11.2. […] The minority of 10% are associated with germline mutations and about half of these are found in association with neurofibromatosis 2 (NF2) and the other half in association with schwannomatosis.

• #39 Malignant Peripheral Nerve Sheath Tumour – SFA

  https://curesarcoma.org/sarcoma-subtypes/malignant-peripheral-nerve-sheath-tumour/

  Malignant peripheral nerve sheath tumor (MPNST) is a malignant spindle cell tumor often arising from a peripheral nerve, from a pre-existing benign nerve sheath tumor, or in a patient with neurofibromatosis type 1 (NF1). […] MPNST may be associated with irradiation or NF1. […] Despite different clinical presentations (e.g., NF1-associated, sporadic de novo, or radiotherapy-associated), recent genomic studies of MPNSTs demonstrated highly frequent and concurrent inactivating mutations in three pathways: NF1, CDKN2A/CDKN2B, and PRC2 core components (EED or SUZ12), resulting in complete loss of function. […] In NF1-associated peripheral nerve sheath tumors, as benign precursor plexiform neurofibroma progresses into atypical neurofibroma / atypical neurofibromatous neoplasm of uncertain biological potential and/or transforms to high-grade MPNST, it is accompanied by progressive genomic alterations that inactivate the neurofibromin (NF1), p16/p15 (CDKN2A/CDKN2B), and PRC2 pathways and increased genomic copy-number variations, respectively.

• #40 Malignant Peripheral Nerve Sheath Tumour – SFA

  https://curesarcoma.org/sarcoma-subtypes/malignant-peripheral-nerve-sheath-tumour/

  Malignant peripheral nerve sheath tumor (MPNST) is a malignant spindle cell tumor often arising from a peripheral nerve, from a pre-existing benign nerve sheath tumor, or in a patient with neurofibromatosis type 1 (NF1). […] MPNST may be associated with irradiation or NF1. […] Despite different clinical presentations (e.g., NF1-associated, sporadic de novo, or radiotherapy-associated), recent genomic studies of MPNSTs demonstrated highly frequent and concurrent inactivating mutations in three pathways: NF1, CDKN2A/CDKN2B, and PRC2 core components (EED or SUZ12), resulting in complete loss of function. […] In NF1-associated peripheral nerve sheath tumors, as benign precursor plexiform neurofibroma progresses into atypical neurofibroma / atypical neurofibromatous neoplasm of uncertain biological potential and/or transforms to high-grade MPNST, it is accompanied by progressive genomic alterations that inactivate the neurofibromin (NF1), p16/p15 (CDKN2A/CDKN2B), and PRC2 pathways and increased genomic copy-number variations, respectively.

• #41

  https://journals.lww.com/jpat/fulltext/2022/26040/an_update_on_oral_peripheral_nerve_sheath_tumors.20.aspx

  Bispecific allelic loss of NF (one hit from the germline and other acquired somatically) resulting in RAS activation is directly assumed to responsible for development of neuro-fibromas. […] Neurofibroma occurs due to nonmyelinating p75+ Schwann cell progenitors which are the major cell for NF 1 loss. […] The RAS/RAF genes are the proto-oncogenes characterized by signal transduction in cell biology. […] Aberrant change in pathways due to genetic or epigenetic alteration is a common cause of cell transformation, cancer development and metastasis, and RTKs play critical roles in development/regulation stemness and proliferation. […] The AKT/mTOR pathways play important roles in modulating cellular functions in response to extracellular signals, such as growth factors and cytokines.

• #42 Malignant Peripheral Nerve Sheath Tumour – SFA

  https://curesarcoma.org/sarcoma-subtypes/malignant-peripheral-nerve-sheath-tumour/

  Malignant peripheral nerve sheath tumor (MPNST) is a malignant spindle cell tumor often arising from a peripheral nerve, from a pre-existing benign nerve sheath tumor, or in a patient with neurofibromatosis type 1 (NF1). […] MPNST may be associated with irradiation or NF1. […] Despite different clinical presentations (e.g., NF1-associated, sporadic de novo, or radiotherapy-associated), recent genomic studies of MPNSTs demonstrated highly frequent and concurrent inactivating mutations in three pathways: NF1, CDKN2A/CDKN2B, and PRC2 core components (EED or SUZ12), resulting in complete loss of function. […] In NF1-associated peripheral nerve sheath tumors, as benign precursor plexiform neurofibroma progresses into atypical neurofibroma / atypical neurofibromatous neoplasm of uncertain biological potential and/or transforms to high-grade MPNST, it is accompanied by progressive genomic alterations that inactivate the neurofibromin (NF1), p16/p15 (CDKN2A/CDKN2B), and PRC2 pathways and increased genomic copy-number variations, respectively.

• #43 Mayo Clinic Health Library – Peripheral nerve tumors | Swiss Medical Network

  https://www.swissmedical.net/en/healtcare-library/con-20213617

  It’s not clear why most peripheral nerve tumors develop. Some are linked to known inherited syndromes, such as neurofibromatosis (types 1 and 2) and schwannomatosis. Others may be caused by changes in a gene. […] Peripheral nerve tumors are more common in people who have: […] Neurofibromatosis (types 1 and 2) and schwannomatosis. In these disorders, tumors develop on or near the nerves throughout the body. There are often multiple tumors. They can lead to a variety of symptoms depending on where they are in the body. These tumors are usually not cancerous. […] A history of radiation treatment. A person who was exposed to radiation is at higher risk of developing peripheral nerve tumors years later.

• #44 Peripheral nerve tumors | Health Library | Memorial Health System

  https://www.mhsystem.org/health-library/con-20213617/

  Peripheral nerve tumors can occur anywhere in the body. Most of them are benign, meaning theyre not cancerous. But they can lead to pain, nerve damage and loss of function in the affected area. […] Its not clear why most peripheral nerve tumors develop. Some are linked to known inherited syndromes, such as neurofibromatosis (types 1 and 2) and schwannomatosis. Others may be caused by changes in a gene. […] Peripheral nerve tumors are more common in people who have: Neurofibromatosis (types 1 and 2) and schwannomatosis. In these disorders, tumors develop on or near the nerves throughout the body. There are often multiple tumors. They can lead to a variety of symptoms depending on where they are in the body. These tumors are usually not cancerous. […] A person who was exposed to radiation is at higher risk of developing peripheral nerve tumors years later.

• #45 Nerve Sheath Tumors: Definition & Types

  https://my.clevelandclinic.org/health/diseases/22526-nerve-sheath-tumors

  Genetic changes play an important role in the development of nerve sheath tumors. Alteration of the NF2 gene is linked to schwannomas, while the NF1 gene is associated with neurofibromas. […] Most often, these genetic changes are sporadic and happen randomly. A small fraction of schwannomas and neurofibromas are caused by a rare, genetic disease that runs in families called neurofibromatosis. […] The types of neurofibromatosis are: Neurofibromatosis type 1 (NF1): People with NF1 have multiple neurofibromas. They might also develop plexiform neuromas and are at higher risk of malignant peripheral nerve sheath tumors. […] Neurofibromatosis type 2 (NF2): Nearly all people with NF2 develop vestibular schwannomas in both ears before age 30. […] Malignant peripheral nerve sheath tumors have a poor prognosis, especially if the tumor is larger than 2 inches. Fewer than half of people with this condition live five years after diagnosis.

• #46 Nerve Tumors | Brain Institute | OHSU

  https://www.ohsu.edu/brain-institute/nerve-tumors

  Nerve tumors are abnormal masses that grow on or in peripheral nerves, the nerves that branch from the brain and spinal cord through the rest of the body. […] Most of the time, nerve tumors are not linked to any risk factor or known cause. Known risk factors include: […] Each type is linked to a different genetic defect. These defects can be inherited (passed down in families), or spontaneous (arising for unknown reasons). […] Neurofibromatosis 1: This is the most common neurofibromatosis disorder, affecting up to about one in 3,000 Americans. Its also known as NF1. It has a range of symptoms, including tumors that range from small nodules to large lumps. Most are benign tumors called neurofibromas. […] Neurofibromatosis 2: This type, also called NF2, is linked to slow-growing nerve tumors called schwannomas. Schwannomas develop from the Schwann cells that form nerve sheaths. Most people with NF2 develop vestibular schwannomas tumors on the vestibular nerves that link each inner ear to the brain by age 30. […] Each type is linked to a different genetic defect. These defects can be inherited (passed down in families), or spontaneous (arising for unknown reasons).

• #47 Pathology Outlines – Malignant peripheral nerve sheath tumor (MPNST)

  https://www.pathologyoutlines.com/topic/softtissuempnst.html

  Transformation process is accompanied by progressive genomic changes involving NF1, CDKN2A / CDKN2B and PRC2 (Hum Pathol 2017;67:1) […] Radiation therapy predisposes to the development of secondary sarcomas through repeated DNA damage and defective repair […] Other nerve sheath tumors (schwannoma, ganglioneuroma) may rarely give rise to secondary MPNST (Am J Surg Pathol 1994;18:882, Am J Surg Pathol 2001;25:13, Pathology 2015;47:595, Histopathology 1988;12:445) […] Plexiform neurofibroma is a common precursor lesion in patients with NF1 […] Patients with NF1 have an 8 – 13% lifetime risk of developing MPNST […] 10 – 15% of plexiform neurofibromas transform to MPNST (Hum Mutat 2008;29:E103) […] […] […] See Epidemiology

• #48 Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management

  https://www.mdpi.com/2072-6694/15/4/1077

  Malignant peripheral nerve sheath tumor (MPNST) is an aggressive soft tissue sarcoma with limited therapeutic options and a poor prognosis. Although neurofibromatosis type 1 (NF1) and radiation exposure have been identified as risk factors for MPNST, the genetic and molecular mechanisms underlying MPNST pathogenesis have only lately been roughly elucidated. […] Neurofibromatosis type 1 (NF1) is a complex autosomal dominant disorder characterized by various germline mutations and clinical manifestations in multiple organs. […] The main clinical manifestations of NF1 include pigmented lesions, cafe-au-lait macules, skin fold freckles, Lisch nodules, dermal neurofibromas, and peripheral nerve tumors. MPNST is the leading cause of premature death in NF1 patients. […] Approximately 10–13% of MPNST patients have a history of therapeutic irradiation.

• #49 Nerve Tumors | Brain Institute | OHSU

  https://www.ohsu.edu/brain-institute/nerve-tumors

  Nerve tumors are abnormal masses that grow on or in peripheral nerves, the nerves that branch from the brain and spinal cord through the rest of the body. […] Most of the time, nerve tumors are not linked to any risk factor or known cause. Known risk factors include: […] Each type is linked to a different genetic defect. These defects can be inherited (passed down in families), or spontaneous (arising for unknown reasons). […] Neurofibromatosis 1: This is the most common neurofibromatosis disorder, affecting up to about one in 3,000 Americans. Its also known as NF1. It has a range of symptoms, including tumors that range from small nodules to large lumps. Most are benign tumors called neurofibromas. […] Neurofibromatosis 2: This type, also called NF2, is linked to slow-growing nerve tumors called schwannomas. Schwannomas develop from the Schwann cells that form nerve sheaths. Most people with NF2 develop vestibular schwannomas tumors on the vestibular nerves that link each inner ear to the brain by age 30. […] Each type is linked to a different genetic defect. These defects can be inherited (passed down in families), or spontaneous (arising for unknown reasons).

• #50 Nerve Tumors | Brain Institute | OHSU

  https://www.ohsu.edu/brain-institute/nerve-tumors

  Nerve tumors are abnormal masses that grow on or in peripheral nerves, the nerves that branch from the brain and spinal cord through the rest of the body. […] Most of the time, nerve tumors are not linked to any risk factor or known cause. Known risk factors include: […] Each type is linked to a different genetic defect. These defects can be inherited (passed down in families), or spontaneous (arising for unknown reasons). […] Neurofibromatosis 1: This is the most common neurofibromatosis disorder, affecting up to about one in 3,000 Americans. Its also known as NF1. It has a range of symptoms, including tumors that range from small nodules to large lumps. Most are benign tumors called neurofibromas. […] Neurofibromatosis 2: This type, also called NF2, is linked to slow-growing nerve tumors called schwannomas. Schwannomas develop from the Schwann cells that form nerve sheaths. Most people with NF2 develop vestibular schwannomas tumors on the vestibular nerves that link each inner ear to the brain by age 30. […] Each type is linked to a different genetic defect. These defects can be inherited (passed down in families), or spontaneous (arising for unknown reasons).

• #51 Schwannoma: Symptoms, Causes, Treatment, and More

  https://www.healthline.com/health/schwannoma

  Aside from NF2 and schwannomatosis, researchers dont know what causes schwannomas. People with a family history of spinal cancer are more likely to have a spinal schwannoma, which suggests they could be genetic. Exposure to radiation is another possible cause. […] Most problems caused by schwannomas are the result of the tumor becoming large and putting pressure on nearby nerves.

• #52 Schwannoma – Symptoms, Causes, TreatmentsSecond Opinion IconGroup 9Group 49

  https://www.barrowneuro.org/condition/schwannoma/

  Schwannomas only occur on the nerves of the peripheral nervous system, outside of the brain and spinal cord. […] The exact cause of schwannomas is not fully understood. They can sometimes be associated with genetic conditions called neurofibromatosis type 2 (NF2) and schwannomatosis. […] Schwannomas are rare, with less than 200,000 diagnosed cases yearly in the United States. However, they are the most common tumors of peripheral nerves in adults. […] Schwannomas can occur at any age but are most commonly diagnosed in adults between 20 and 50. They are slightly more common in women than in men. […] Schwannoma can occur in people of all ages. However, they are more common in people with the genetic disorders neurofibromatosis type 2 (NF2) and schwannomatosis. […] These tumors are often associated with genetic conditions, such as neurofibromatosis type 1 (NF1), which significantly increases the risk of developing MPNSTs.

• #53

  https://continentalhospitals.com/diseases/benign-peripheral-nerve-tumor/

  One of the primary risk factors for benign peripheral nerve tumors is a genetic predisposition. Research suggests that certain inherited conditions, such as neurofibromatosis type 1 and schwannomatosis, can significantly increase the chances of developing these tumors. Individuals with a family history of these conditions should be particularly vigilant in monitoring their health. Another potential risk factor is exposure to certain environmental toxins or radiation. Studies have indicated a possible link between occupational exposure to chemicals or radiation and the development of benign peripheral nerve tumors. It is important for individuals working in industries where such exposures are common to take appropriate precautions and follow safety guidelines. Age can also play a role in determining the risk of developing these tumors. While they can occur at any age, they are more commonly observed in adults between the ages of 30 and 60. Regular medical check-ups and screenings become increasingly important as individuals reach this age range. It is worth noting that while these risk factors may increase the likelihood of developing benign peripheral nerve tumors, they do not guarantee their occurrence. Many cases occur sporadically without any identifiable cause or predisposing factors. By understanding these risk factors, individuals can take proactive steps towards early detection, proper diagnosis, and timely treatment if necessary. Regular communication with healthcare professionals can provide valuable guidance on managing individual risks and maintaining overall well-being.

• #54 Schwannoma – Symptoms, Causes, TreatmentsSecond Opinion IconGroup 9Group 49

  https://www.barrowneuro.org/condition/schwannoma/

  Schwannomas only occur on the nerves of the peripheral nervous system, outside of the brain and spinal cord. […] The exact cause of schwannomas is not fully understood. They can sometimes be associated with genetic conditions called neurofibromatosis type 2 (NF2) and schwannomatosis. […] Schwannomas are rare, with less than 200,000 diagnosed cases yearly in the United States. However, they are the most common tumors of peripheral nerves in adults. […] Schwannomas can occur at any age but are most commonly diagnosed in adults between 20 and 50. They are slightly more common in women than in men. […] Schwannoma can occur in people of all ages. However, they are more common in people with the genetic disorders neurofibromatosis type 2 (NF2) and schwannomatosis. […] These tumors are often associated with genetic conditions, such as neurofibromatosis type 1 (NF1), which significantly increases the risk of developing MPNSTs.

• #55 Schwannoma – Symptoms, Causes, TreatmentsSecond Opinion IconGroup 9Group 49

  https://www.barrowneuro.org/condition/schwannoma/

  Schwannomas only occur on the nerves of the peripheral nervous system, outside of the brain and spinal cord. […] The exact cause of schwannomas is not fully understood. They can sometimes be associated with genetic conditions called neurofibromatosis type 2 (NF2) and schwannomatosis. […] Schwannomas are rare, with less than 200,000 diagnosed cases yearly in the United States. However, they are the most common tumors of peripheral nerves in adults. […] Schwannomas can occur at any age but are most commonly diagnosed in adults between 20 and 50. They are slightly more common in women than in men. […] Schwannoma can occur in people of all ages. However, they are more common in people with the genetic disorders neurofibromatosis type 2 (NF2) and schwannomatosis. […] These tumors are often associated with genetic conditions, such as neurofibromatosis type 1 (NF1), which significantly increases the risk of developing MPNSTs.

• #56

  https://continentalhospitals.com/diseases/benign-peripheral-nerve-tumor/

  One of the primary risk factors for benign peripheral nerve tumors is a genetic predisposition. Research suggests that certain inherited conditions, such as neurofibromatosis type 1 and schwannomatosis, can significantly increase the chances of developing these tumors. Individuals with a family history of these conditions should be particularly vigilant in monitoring their health. Another potential risk factor is exposure to certain environmental toxins or radiation. Studies have indicated a possible link between occupational exposure to chemicals or radiation and the development of benign peripheral nerve tumors. It is important for individuals working in industries where such exposures are common to take appropriate precautions and follow safety guidelines. Age can also play a role in determining the risk of developing these tumors. While they can occur at any age, they are more commonly observed in adults between the ages of 30 and 60. Regular medical check-ups and screenings become increasingly important as individuals reach this age range. It is worth noting that while these risk factors may increase the likelihood of developing benign peripheral nerve tumors, they do not guarantee their occurrence. Many cases occur sporadically without any identifiable cause or predisposing factors. By understanding these risk factors, individuals can take proactive steps towards early detection, proper diagnosis, and timely treatment if necessary. Regular communication with healthcare professionals can provide valuable guidance on managing individual risks and maintaining overall well-being.

• #57 What Are Malignant Peripheral Nerve Sheath Tumors?

  https://www.rwjbh.org/treatment-care/neuroscience/neurology/conditions/malignant-peripheral-nerve-sheath-tumors/

  Malignant peripheral nerve sheath tumors, also known as neurofibrosarcomas, are found in the protective lining, or myelin sheath, surrounding the peripheral (outside) nerves of the spinal cord the nerves that reach out to the rest of the body. These rare cancerous tumors occur most commonly in the muscle, fat, nerves, and other soft tissue of the torso, arms, or legs. […] The exact causes of these tumors arent known, but they begin when a cell in the sheath develops a DNA mutation. They grow and divide much faster than normal. The excess of cells forms invasive, spreadable tumors. […] Malignant peripheral nerve sheath tumors are most common in young adults and middle-aged adults, and more than half are found in people who have neurofibromatosis 1 (a non-cancerous condition that causes bone deformities).

• #58 Mayo Clinic Health Library – Peripheral nerve tumors | Swiss Medical Network

  https://www.swissmedical.net/en/healtcare-library/con-20213617

  It’s not clear why most peripheral nerve tumors develop. Some are linked to known inherited syndromes, such as neurofibromatosis (types 1 and 2) and schwannomatosis. Others may be caused by changes in a gene. […] Peripheral nerve tumors are more common in people who have: […] Neurofibromatosis (types 1 and 2) and schwannomatosis. In these disorders, tumors develop on or near the nerves throughout the body. There are often multiple tumors. They can lead to a variety of symptoms depending on where they are in the body. These tumors are usually not cancerous. […] A history of radiation treatment. A person who was exposed to radiation is at higher risk of developing peripheral nerve tumors years later.

• #59 Peripheral nerve tumors | Health Library | Memorial Health System

  https://www.mhsystem.org/health-library/con-20213617/

  Peripheral nerve tumors can occur anywhere in the body. Most of them are benign, meaning theyre not cancerous. But they can lead to pain, nerve damage and loss of function in the affected area. […] Its not clear why most peripheral nerve tumors develop. Some are linked to known inherited syndromes, such as neurofibromatosis (types 1 and 2) and schwannomatosis. Others may be caused by changes in a gene. […] Peripheral nerve tumors are more common in people who have: Neurofibromatosis (types 1 and 2) and schwannomatosis. In these disorders, tumors develop on or near the nerves throughout the body. There are often multiple tumors. They can lead to a variety of symptoms depending on where they are in the body. These tumors are usually not cancerous. […] A person who was exposed to radiation is at higher risk of developing peripheral nerve tumors years later.

• #60 Malignant peripheral nerve sheath tumors | Altru Health System

  https://www.altru.org/health-library/conditions/malignant-peripheral-nerve-sheath-tumors

  Malignant peripheral nerve sheath tumors are rare cancers that start in the lining of the nerves. […] It’s not clear what causes most malignant peripheral nerve sheath tumors. […] Experts know that these cancers begin when a cell in the lining around a nerve gets changes in its DNA. […] The changes tell the cells to make more cells quickly. […] These cells continue to live when healthy cells die as part of their life cycle. […] The cells then can form a mass called a tumor. […] Factors that increase the risk of malignant peripheral nerve sheath tumors include: […] A malignant peripheral nerve sheath tumor might occur in the area treated with radiation 10 to 20 years after treatment. […] Malignant peripheral nerve sheath tumors can develop from nerve tumors that aren’t cancerous, such as neurofibroma. […] Malignant peripheral nerve sheath tumors occur more often in people with neurofibromatosis 1.

• #61 Malignant Peripheral Nerve Sheath Tumors – Rein in Sarcoma

  https://www.reininsarcoma.org/mpnst/

  Another risk factor for MPNST is previous radiation therapy. While the prevalence of MPNSTs in the general population is only 0.001%, the risk of developing a MPNST as a secondary malignancy due to prior radiotherapy is 0.06%. A MPNST may develop in a radiation-treated area within 10-20 years of receiving treatment. This etiology is often linked with radiation treatment for childhood cancer. Up to 10% of MPNSTs are attributed to prior radiation treatment. […] Malignant transformation of a benign plexiform neurofibroma may first present as new, intensifying or persistent pain localized to the pre-existing mass.

• #62 Malignant Peripheral Nerve Sheath Tumors – Rein in Sarcoma

  https://www.reininsarcoma.org/mpnst/

  Another risk factor for MPNST is previous radiation therapy. While the prevalence of MPNSTs in the general population is only 0.001%, the risk of developing a MPNST as a secondary malignancy due to prior radiotherapy is 0.06%. A MPNST may develop in a radiation-treated area within 10-20 years of receiving treatment. This etiology is often linked with radiation treatment for childhood cancer. Up to 10% of MPNSTs are attributed to prior radiation treatment. […] Malignant transformation of a benign plexiform neurofibroma may first present as new, intensifying or persistent pain localized to the pre-existing mass.

• #63 Malignant peripheral nerve sheath tumors | Altru Health System

  https://www.altru.org/health-library/conditions/malignant-peripheral-nerve-sheath-tumors

  Malignant peripheral nerve sheath tumors are rare cancers that start in the lining of the nerves. […] It’s not clear what causes most malignant peripheral nerve sheath tumors. […] Experts know that these cancers begin when a cell in the lining around a nerve gets changes in its DNA. […] The changes tell the cells to make more cells quickly. […] These cells continue to live when healthy cells die as part of their life cycle. […] The cells then can form a mass called a tumor. […] Factors that increase the risk of malignant peripheral nerve sheath tumors include: […] A malignant peripheral nerve sheath tumor might occur in the area treated with radiation 10 to 20 years after treatment. […] Malignant peripheral nerve sheath tumors can develop from nerve tumors that aren’t cancerous, such as neurofibroma. […] Malignant peripheral nerve sheath tumors occur more often in people with neurofibromatosis 1.

• #64 Nerve Sheath Tumor Treatment in New Jersey – Centers for Neurosurgery, Spine & Orthopedics

  https://www.cnsomd.com/surgery-conditions/nerve-tumors/nerve-sheath-tumor/

  MPNST is a rare type of sarcoma that accounts for only 5%-10% of the total sarcoma cases. It commonly affects the youth and middle-aged individuals with a genetic condition called neurofibromatosis type 1 (NF1). About half of MPNST patients have NF1, and virtually 15% of persons with NF1 develop MPNST in their lifetime.

• #65 Malignant peripheral nerve sheath tumors | Altru Health System

  https://www.altru.org/health-library/conditions/malignant-peripheral-nerve-sheath-tumors

  Malignant peripheral nerve sheath tumors are rare cancers that start in the lining of the nerves. […] It’s not clear what causes most malignant peripheral nerve sheath tumors. […] Experts know that these cancers begin when a cell in the lining around a nerve gets changes in its DNA. […] The changes tell the cells to make more cells quickly. […] These cells continue to live when healthy cells die as part of their life cycle. […] The cells then can form a mass called a tumor. […] Factors that increase the risk of malignant peripheral nerve sheath tumors include: […] A malignant peripheral nerve sheath tumor might occur in the area treated with radiation 10 to 20 years after treatment. […] Malignant peripheral nerve sheath tumors can develop from nerve tumors that aren’t cancerous, such as neurofibroma. […] Malignant peripheral nerve sheath tumors occur more often in people with neurofibromatosis 1.

• #66 Malignant Peripheral Nerve Sheath Tumor (MPNST)

  https://my.clevelandclinic.org/health/diseases/malignant-peripheral-nerve-sheath-tumor-mpnst

  People who have the inherited disorder neurofibromatosis type 1 (NF1) often develop MPNST. Between 25% and 50% of people who have a malignant peripheral nerve sheath tumor also have NF1. […] Studies show neurofibromatosis type 1 accounts for 50% of malignant peripheral nerve sheath tumors. Other causes include: […] Genetic mutations: Researchers have found several different genetic mutations that turn normal nerve sheath cells into abnormal cells that multiply and create tumors. […] Certain neurofibromas: People with plexiform neurofibroma have an increased risk for MPNST.

• #67 Malignant Peripheral Nerve Sheath Tumor (MPNST)

  https://my.clevelandclinic.org/health/diseases/malignant-peripheral-nerve-sheath-tumor-mpnst

  People who have the inherited disorder neurofibromatosis type 1 (NF1) often develop MPNST. Between 25% and 50% of people who have a malignant peripheral nerve sheath tumor also have NF1. […] Studies show neurofibromatosis type 1 accounts for 50% of malignant peripheral nerve sheath tumors. Other causes include: […] Genetic mutations: Researchers have found several different genetic mutations that turn normal nerve sheath cells into abnormal cells that multiply and create tumors. […] Certain neurofibromas: People with plexiform neurofibroma have an increased risk for MPNST.

• #68 Benign peripheral nerve sheath tumors: an interdisciplinary diagnostic and therapeutic challenge

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10439084/

  A benign peripheral nerve sheath tumor (bPNST) is a rare lesion associated with peripheral nerval structures. […] Therefore, we analyzed patients treated for bPNST in our specialized institution with a primary focus on prior misdiagnosis and possible mistreatment. […] An incorrect primary diagnosis was detected in 44.7% (n=38), leading to suboptimal or insufficient treatment in these cases. […] For the first time, our data shows the quantity and impact of incorrect initial diagnosis in bPNST causing a delay in causative treatment or resulting in unnecessary or potentially harmful treatment. […] A misdiagnosis occurred, if the final diagnosis was inconsistent with the diagnosis which was set up by the doctor who treated the patient at first. […] We were able to identify four main causes resulting in misdiagnosis of bPNST.

• #69

  https://link.springer.com/article/10.1007/s10143-023-02107-z

  A benign peripheral nerve sheath tumor (bPNST) is a rare lesion associated with peripheral nerval structures. […] Therefore, we aimed to evaluate the rate of primary misdiagnosis and mistreatment in patients suffering from deep-seated bPNSTs. Furthermore, we aimed to identify causative factors for mistreatment. […] A misdiagnosis occurred, if the final diagnosis was inconsistent with the diagnosis which was set up by the doctor who treated the patient at first. […] We were able to identify four main causes resulting in misdiagnosis of bPNST. Firstly, variation of different symptoms and especially failure to recognize and interpret specific symptoms (for example, a positive Hoffmann Tinels sign) may lead to misdiagnosis concerning a non-pathological MRI of the spine. […] Secondly, symptom presentation of bPNST might be similar or mimic symptoms of more common diseases.

• #70 Benign peripheral nerve sheath tumors: an interdisciplinary diagnostic and therapeutic challenge

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10439084/

  A benign peripheral nerve sheath tumor (bPNST) is a rare lesion associated with peripheral nerval structures. […] Therefore, we analyzed patients treated for bPNST in our specialized institution with a primary focus on prior misdiagnosis and possible mistreatment. […] An incorrect primary diagnosis was detected in 44.7% (n=38), leading to suboptimal or insufficient treatment in these cases. […] For the first time, our data shows the quantity and impact of incorrect initial diagnosis in bPNST causing a delay in causative treatment or resulting in unnecessary or potentially harmful treatment. […] A misdiagnosis occurred, if the final diagnosis was inconsistent with the diagnosis which was set up by the doctor who treated the patient at first. […] We were able to identify four main causes resulting in misdiagnosis of bPNST.

• #71 Benign peripheral nerve sheath tumors: an interdisciplinary diagnostic and therapeutic challenge

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10439084/

  A benign peripheral nerve sheath tumor (bPNST) is a rare lesion associated with peripheral nerval structures. […] Therefore, we analyzed patients treated for bPNST in our specialized institution with a primary focus on prior misdiagnosis and possible mistreatment. […] An incorrect primary diagnosis was detected in 44.7% (n=38), leading to suboptimal or insufficient treatment in these cases. […] For the first time, our data shows the quantity and impact of incorrect initial diagnosis in bPNST causing a delay in causative treatment or resulting in unnecessary or potentially harmful treatment. […] A misdiagnosis occurred, if the final diagnosis was inconsistent with the diagnosis which was set up by the doctor who treated the patient at first. […] We were able to identify four main causes resulting in misdiagnosis of bPNST.

• #72 Benign peripheral nerve sheath tumors: an interdisciplinary diagnostic and therapeutic challenge

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10439084/

  A benign peripheral nerve sheath tumor (bPNST) is a rare lesion associated with peripheral nerval structures. […] Therefore, we analyzed patients treated for bPNST in our specialized institution with a primary focus on prior misdiagnosis and possible mistreatment. […] An incorrect primary diagnosis was detected in 44.7% (n=38), leading to suboptimal or insufficient treatment in these cases. […] For the first time, our data shows the quantity and impact of incorrect initial diagnosis in bPNST causing a delay in causative treatment or resulting in unnecessary or potentially harmful treatment. […] A misdiagnosis occurred, if the final diagnosis was inconsistent with the diagnosis which was set up by the doctor who treated the patient at first. […] We were able to identify four main causes resulting in misdiagnosis of bPNST.

• #73

  https://link.springer.com/article/10.1007/s10143-023-02107-z

  A benign peripheral nerve sheath tumor (bPNST) is a rare lesion associated with peripheral nerval structures. […] Therefore, we aimed to evaluate the rate of primary misdiagnosis and mistreatment in patients suffering from deep-seated bPNSTs. Furthermore, we aimed to identify causative factors for mistreatment. […] A misdiagnosis occurred, if the final diagnosis was inconsistent with the diagnosis which was set up by the doctor who treated the patient at first. […] We were able to identify four main causes resulting in misdiagnosis of bPNST. Firstly, variation of different symptoms and especially failure to recognize and interpret specific symptoms (for example, a positive Hoffmann Tinels sign) may lead to misdiagnosis concerning a non-pathological MRI of the spine. […] Secondly, symptom presentation of bPNST might be similar or mimic symptoms of more common diseases.

• #74

  https://link.springer.com/article/10.1007/s10143-023-02107-z

  A benign peripheral nerve sheath tumor (bPNST) is a rare lesion associated with peripheral nerval structures. […] Therefore, we aimed to evaluate the rate of primary misdiagnosis and mistreatment in patients suffering from deep-seated bPNSTs. Furthermore, we aimed to identify causative factors for mistreatment. […] A misdiagnosis occurred, if the final diagnosis was inconsistent with the diagnosis which was set up by the doctor who treated the patient at first. […] We were able to identify four main causes resulting in misdiagnosis of bPNST. Firstly, variation of different symptoms and especially failure to recognize and interpret specific symptoms (for example, a positive Hoffmann Tinels sign) may lead to misdiagnosis concerning a non-pathological MRI of the spine. […] Secondly, symptom presentation of bPNST might be similar or mimic symptoms of more common diseases.

• #75

  https://link.springer.com/article/10.1007/s10143-023-02107-z

  A benign peripheral nerve sheath tumor (bPNST) is a rare lesion associated with peripheral nerval structures. […] Therefore, we aimed to evaluate the rate of primary misdiagnosis and mistreatment in patients suffering from deep-seated bPNSTs. Furthermore, we aimed to identify causative factors for mistreatment. […] A misdiagnosis occurred, if the final diagnosis was inconsistent with the diagnosis which was set up by the doctor who treated the patient at first. […] We were able to identify four main causes resulting in misdiagnosis of bPNST. Firstly, variation of different symptoms and especially failure to recognize and interpret specific symptoms (for example, a positive Hoffmann Tinels sign) may lead to misdiagnosis concerning a non-pathological MRI of the spine. […] Secondly, symptom presentation of bPNST might be similar or mimic symptoms of more common diseases.

• #76

  https://link.springer.com/article/10.1007/s10143-023-02107-z

  A benign peripheral nerve sheath tumor (bPNST) is a rare lesion associated with peripheral nerval structures. […] Therefore, we aimed to evaluate the rate of primary misdiagnosis and mistreatment in patients suffering from deep-seated bPNSTs. Furthermore, we aimed to identify causative factors for mistreatment. […] A misdiagnosis occurred, if the final diagnosis was inconsistent with the diagnosis which was set up by the doctor who treated the patient at first. […] We were able to identify four main causes resulting in misdiagnosis of bPNST. Firstly, variation of different symptoms and especially failure to recognize and interpret specific symptoms (for example, a positive Hoffmann Tinels sign) may lead to misdiagnosis concerning a non-pathological MRI of the spine. […] Secondly, symptom presentation of bPNST might be similar or mimic symptoms of more common diseases.

• #77 Cauda equina malignant peripheral nerve sheath tumor presenting with subarachnoid hemorrhage: a case report | Neurocirugía (English edition)

  https://www.revistaneurocirugia.com/en-cauda-equina-malignant-peripheral-nerve-articulo-S2529849624000583

  Moreover, despite recent reviews on MPNST reporting clinical and radiological findings, it remains a rare entity and its diagnosis needs a thorough work-up. In the reported cases of MPNST, the initial diagnosis was a disc herniation based on symptoms, radiological findings, and surgical evidence until the pathology results were obtained. However, in our case, the diagnostic work-up lead towards a tumor etiology due to the presence of an intradural lesion with diffuse contrast enhancement, and intraoperative SSAH finding. […] Among spinal hematomas, SSAH has a very low frequency. This presentation is usually related to intracranial hemorrhage secondary to trauma or aneurysm rupture, spinal tumors, and less commonly coagulopathies and spinal trauma. Furthermore, intraoperative evidence of SSAH is an infrequent finding during tumor removal. When SSAHs was tumor-related, the main types of tumor were ependymoma, neurofibroma, and astrocytoma. To our knowledge, this is the first report of SSAH related to intradural lumbar spine MPNST.

• #78 Cauda equina malignant peripheral nerve sheath tumor presenting with subarachnoid hemorrhage: a case report | Neurocirugía (English edition)

  https://www.revistaneurocirugia.com/en-cauda-equina-malignant-peripheral-nerve-articulo-S2529849624000583

  Moreover, despite recent reviews on MPNST reporting clinical and radiological findings, it remains a rare entity and its diagnosis needs a thorough work-up. In the reported cases of MPNST, the initial diagnosis was a disc herniation based on symptoms, radiological findings, and surgical evidence until the pathology results were obtained. However, in our case, the diagnostic work-up lead towards a tumor etiology due to the presence of an intradural lesion with diffuse contrast enhancement, and intraoperative SSAH finding. […] Among spinal hematomas, SSAH has a very low frequency. This presentation is usually related to intracranial hemorrhage secondary to trauma or aneurysm rupture, spinal tumors, and less commonly coagulopathies and spinal trauma. Furthermore, intraoperative evidence of SSAH is an infrequent finding during tumor removal. When SSAHs was tumor-related, the main types of tumor were ependymoma, neurofibroma, and astrocytoma. To our knowledge, this is the first report of SSAH related to intradural lumbar spine MPNST.

• #79

  https://link.springer.com/article/10.1007/s10143-023-02107-z

  Lastly, in the German medical system, general practitioners are the first consultants of the patients and are essential for organizing further therapy at a specialized center (84.7% in our study). […] Our data show the prolonged time for a symptomatic patient to receive a definite diagnosis and adequate therapy in many cases. […] However, chronic pain and the missing explanation of individual symptoms can lead to a significant psychological burden. […] Another reason for mistreatment is the result of a priorly wrong diagnosis. […] This resulted in severe neurological deficits that had to be treated with nerve interposition devices during revision surgery. […] Treatment by an experienced nerve surgeon showed significantly lower rates of mistreatment compared with treatment by other specialists.

• #80

  https://link.springer.com/article/10.1007/s10143-023-02107-z

  Lastly, in the German medical system, general practitioners are the first consultants of the patients and are essential for organizing further therapy at a specialized center (84.7% in our study). […] Our data show the prolonged time for a symptomatic patient to receive a definite diagnosis and adequate therapy in many cases. […] However, chronic pain and the missing explanation of individual symptoms can lead to a significant psychological burden. […] Another reason for mistreatment is the result of a priorly wrong diagnosis. […] This resulted in severe neurological deficits that had to be treated with nerve interposition devices during revision surgery. […] Treatment by an experienced nerve surgeon showed significantly lower rates of mistreatment compared with treatment by other specialists.

• #81 Benign peripheral nerve sheath tumors: an interdisciplinary diagnostic and therapeutic challenge

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10439084/

  The misinterpretation of a symptom and/or the radiological imaging may lead to unnecessary or inappropriate surgical treatment unrelated to the actual disease or to a more radical surgical treatment. […] Our data show the prolonged time for a symptomatic patient to receive a definite diagnosis and adequate therapy in many cases. […] However, chronic pain and the missing explanation of individual symptoms can lead to a significant psychological burden. […] Furthermore, a CT-guided biopsy bears the risk of nerve-damaging and is a permanent cause for discussion between the different disciplines. […] Treatment by an experienced nerve surgeon showed significantly lower rates of mistreatment compared with treatment by other specialists.

• #82

  https://link.springer.com/article/10.1007/s10143-023-02107-z

  Lastly, in the German medical system, general practitioners are the first consultants of the patients and are essential for organizing further therapy at a specialized center (84.7% in our study). […] Our data show the prolonged time for a symptomatic patient to receive a definite diagnosis and adequate therapy in many cases. […] However, chronic pain and the missing explanation of individual symptoms can lead to a significant psychological burden. […] Another reason for mistreatment is the result of a priorly wrong diagnosis. […] This resulted in severe neurological deficits that had to be treated with nerve interposition devices during revision surgery. […] Treatment by an experienced nerve surgeon showed significantly lower rates of mistreatment compared with treatment by other specialists.

• #83 Benign peripheral nerve sheath tumors: an interdisciplinary diagnostic and therapeutic challenge

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10439084/

  The misinterpretation of a symptom and/or the radiological imaging may lead to unnecessary or inappropriate surgical treatment unrelated to the actual disease or to a more radical surgical treatment. […] Our data show the prolonged time for a symptomatic patient to receive a definite diagnosis and adequate therapy in many cases. […] However, chronic pain and the missing explanation of individual symptoms can lead to a significant psychological burden. […] Furthermore, a CT-guided biopsy bears the risk of nerve-damaging and is a permanent cause for discussion between the different disciplines. […] Treatment by an experienced nerve surgeon showed significantly lower rates of mistreatment compared with treatment by other specialists.

• #84

  https://link.springer.com/article/10.1007/s10143-023-02107-z

  Lastly, in the German medical system, general practitioners are the first consultants of the patients and are essential for organizing further therapy at a specialized center (84.7% in our study). […] Our data show the prolonged time for a symptomatic patient to receive a definite diagnosis and adequate therapy in many cases. […] However, chronic pain and the missing explanation of individual symptoms can lead to a significant psychological burden. […] Another reason for mistreatment is the result of a priorly wrong diagnosis. […] This resulted in severe neurological deficits that had to be treated with nerve interposition devices during revision surgery. […] Treatment by an experienced nerve surgeon showed significantly lower rates of mistreatment compared with treatment by other specialists.

• #85 Benign peripheral nerve sheath tumors: an interdisciplinary diagnostic and therapeutic challenge

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10439084/

  The misinterpretation of a symptom and/or the radiological imaging may lead to unnecessary or inappropriate surgical treatment unrelated to the actual disease or to a more radical surgical treatment. […] Our data show the prolonged time for a symptomatic patient to receive a definite diagnosis and adequate therapy in many cases. […] However, chronic pain and the missing explanation of individual symptoms can lead to a significant psychological burden. […] Furthermore, a CT-guided biopsy bears the risk of nerve-damaging and is a permanent cause for discussion between the different disciplines. […] Treatment by an experienced nerve surgeon showed significantly lower rates of mistreatment compared with treatment by other specialists.

• #86 A Discussion of Malignant Peripheral Nerve Sheath Tumors (MPNSTs) – Neurofibromatosis Program

  https://www.uab.edu/medicine/nfprogram/blog/blog-archive/a-discussion-of-malignant-peripheral-nerve-sheath-tumors-mpnsts

  The focus of this months blog post is a discussion of malignant peripheral nerve sheath tumors (MPNSTs), which represent one of the few potentially life-threatening complications of neurofibromatosis type 1. […] The development of MPNSTs from tumors such as plexiform neurofibromas occurs by the progressive accumulation of genetic changes that are characteristic of cancer. […] The genetic changes in MPNSTs make these tumors difficult to control. […] Because MPNSTs are very challenging to treat, early diagnosis is critical. […] Current NF clinical trials are evaluating chemotherapy as well as other therapeutics targeting genetic changes in the tumor. […] In conclusion, because MPNSTs are difficult to treat, early detection is critically important.

• #87 Cauda equina malignant peripheral nerve sheath tumor presenting with subarachnoid hemorrhage: a case report | Neurocirugía (English edition)

  https://www.revistaneurocirugia.com/en-cauda-equina-malignant-peripheral-nerve-articulo-S2529849624000583

  Malignant peripheral nerve sheath tumors (MPNST) are highly malignant soft tissue neoplasms that originate from the mesenchymal cells residing within the nerve sheath, in most cases from Schwann cells. MPNST predominantly affect young people. Patients with MPNST have a poor prognosis with a 5-year survival rate from 16% to 44% with a local recurrence expected in 38-45% of cases. Metastases are also frequent, mainly to the lungs, liver and brain. […] MPNST are a rare entity with an incidence of 0.001% that represent only 5% of all soft-tissue sarcomas. Spinal MPNST correspond to 23% of all cases, with only 6 cases of intradural lumbar MPNST reported in the literature. Their clinical presentation and diagnostic work-up can be misleading due to the symptomatic and imaging overlap with lumbar disc herniation.

• #88 Cauda equina malignant peripheral nerve sheath tumor presenting with subarachnoid hemorrhage: a case report | Neurocirugía (English edition)

  https://www.revistaneurocirugia.com/en-cauda-equina-malignant-peripheral-nerve-articulo-S2529849624000583

  Moreover, despite recent reviews on MPNST reporting clinical and radiological findings, it remains a rare entity and its diagnosis needs a thorough work-up. In the reported cases of MPNST, the initial diagnosis was a disc herniation based on symptoms, radiological findings, and surgical evidence until the pathology results were obtained. However, in our case, the diagnostic work-up lead towards a tumor etiology due to the presence of an intradural lesion with diffuse contrast enhancement, and intraoperative SSAH finding. […] Among spinal hematomas, SSAH has a very low frequency. This presentation is usually related to intracranial hemorrhage secondary to trauma or aneurysm rupture, spinal tumors, and less commonly coagulopathies and spinal trauma. Furthermore, intraoperative evidence of SSAH is an infrequent finding during tumor removal. When SSAHs was tumor-related, the main types of tumor were ependymoma, neurofibroma, and astrocytoma. To our knowledge, this is the first report of SSAH related to intradural lumbar spine MPNST.

• #89 Cauda equina malignant peripheral nerve sheath tumor presenting with subarachnoid hemorrhage: a case report | Neurocirugía (English edition)

  https://www.revistaneurocirugia.com/en-cauda-equina-malignant-peripheral-nerve-articulo-S2529849624000583

  Moreover, despite recent reviews on MPNST reporting clinical and radiological findings, it remains a rare entity and its diagnosis needs a thorough work-up. In the reported cases of MPNST, the initial diagnosis was a disc herniation based on symptoms, radiological findings, and surgical evidence until the pathology results were obtained. However, in our case, the diagnostic work-up lead towards a tumor etiology due to the presence of an intradural lesion with diffuse contrast enhancement, and intraoperative SSAH finding. […] Among spinal hematomas, SSAH has a very low frequency. This presentation is usually related to intracranial hemorrhage secondary to trauma or aneurysm rupture, spinal tumors, and less commonly coagulopathies and spinal trauma. Furthermore, intraoperative evidence of SSAH is an infrequent finding during tumor removal. When SSAHs was tumor-related, the main types of tumor were ependymoma, neurofibroma, and astrocytoma. To our knowledge, this is the first report of SSAH related to intradural lumbar spine MPNST.

• #90 Cauda equina malignant peripheral nerve sheath tumor presenting with subarachnoid hemorrhage: a case report | Neurocirugía (English edition)

  https://www.revistaneurocirugia.com/en-cauda-equina-malignant-peripheral-nerve-articulo-S2529849624000583

  Moreover, despite recent reviews on MPNST reporting clinical and radiological findings, it remains a rare entity and its diagnosis needs a thorough work-up. In the reported cases of MPNST, the initial diagnosis was a disc herniation based on symptoms, radiological findings, and surgical evidence until the pathology results were obtained. However, in our case, the diagnostic work-up lead towards a tumor etiology due to the presence of an intradural lesion with diffuse contrast enhancement, and intraoperative SSAH finding. […] Among spinal hematomas, SSAH has a very low frequency. This presentation is usually related to intracranial hemorrhage secondary to trauma or aneurysm rupture, spinal tumors, and less commonly coagulopathies and spinal trauma. Furthermore, intraoperative evidence of SSAH is an infrequent finding during tumor removal. When SSAHs was tumor-related, the main types of tumor were ependymoma, neurofibroma, and astrocytoma. To our knowledge, this is the first report of SSAH related to intradural lumbar spine MPNST.

• #91 Cauda equina malignant peripheral nerve sheath tumor presenting with subarachnoid hemorrhage: a case report | Neurocirugía (English edition)

  https://revistaneurocirugia.com/en-cauda-equina-malignant-peripheral-nerve-avance-S2529849624000583

  The acute debut in our case could be explained by hemorrhage with secondary subarachnoid extension of the blood creating increase in the local pressure and roots irritation as the cause of back pain. […] Despite recent reviews on MPNST reporting clinical and radiological findings, it remains a rare entity and its diagnosis needs a thorough work-up. In the reported cases of MPNST, the initial diagnosis was a disc herniation based on symptoms, radiological findings, and surgical evidence until the pathology results were obtained. However, in our case, the diagnostic work-up lead towards a tumor etiology due to the presence of an intradural lesion with diffuse contrast enhancement, and intraoperative SSAH finding. […] Among spinal hematomas, SSAH has a very low frequency. This presentation is usually related to intracranial hemorrhage secondary to trauma or aneurysm rupture, spinal tumors, and less commonly coagulopathies and spinal trauma. Furthermore, intraoperative evidence of SSAH is an infrequent finding during tumor removal.

• #92 Cauda equina malignant peripheral nerve sheath tumor presenting with subarachnoid hemorrhage: a case report | Neurocirugía (English edition)

  https://www.revistaneurocirugia.com/en-cauda-equina-malignant-peripheral-nerve-articulo-S2529849624000583

  Moreover, despite recent reviews on MPNST reporting clinical and radiological findings, it remains a rare entity and its diagnosis needs a thorough work-up. In the reported cases of MPNST, the initial diagnosis was a disc herniation based on symptoms, radiological findings, and surgical evidence until the pathology results were obtained. However, in our case, the diagnostic work-up lead towards a tumor etiology due to the presence of an intradural lesion with diffuse contrast enhancement, and intraoperative SSAH finding. […] Among spinal hematomas, SSAH has a very low frequency. This presentation is usually related to intracranial hemorrhage secondary to trauma or aneurysm rupture, spinal tumors, and less commonly coagulopathies and spinal trauma. Furthermore, intraoperative evidence of SSAH is an infrequent finding during tumor removal. When SSAHs was tumor-related, the main types of tumor were ependymoma, neurofibroma, and astrocytoma. To our knowledge, this is the first report of SSAH related to intradural lumbar spine MPNST.

• #93 Peripheral Neuropathy | Macmillan Cancer Support

  https://www.macmillan.org.uk/cancer-information-and-support/impacts-of-cancer/peripheral-neuropathy

  Different things can cause peripheral neuropathy, such as diabetes, injury, cancer and some cancer treatments. This information is about cancer-related causes of peripheral neuropathy. […] There are different ways that cancer and its treatments can cause peripheral neuropathy: […] Some anti-cancer drugs can cause nerve damage. This is the most common cause of peripheral neuropathy in people with cancer. […] Cancer can cause peripheral neuropathy in one area of the body if the tumour is growing close to a nerve and presses on it. […] Rarely, radiotherapy may damage nerves in the treated area. This can cause symptoms such as numbness and weakness. These may develop months or years after treatment. […] In some types of cancer, the body may make substances that damage peripheral nerves. This is called paraneoplastic syndrome. It may happen in people with lung cancer, myeloma or lymphoma.

• #94 Peripheral Neuropathy | Macmillan Cancer Support

  https://www.macmillan.org.uk/cancer-information-and-support/impacts-of-cancer/peripheral-neuropathy

  Different things can cause peripheral neuropathy, such as diabetes, injury, cancer and some cancer treatments. This information is about cancer-related causes of peripheral neuropathy. […] There are different ways that cancer and its treatments can cause peripheral neuropathy: […] Some anti-cancer drugs can cause nerve damage. This is the most common cause of peripheral neuropathy in people with cancer. […] Cancer can cause peripheral neuropathy in one area of the body if the tumour is growing close to a nerve and presses on it. […] Rarely, radiotherapy may damage nerves in the treated area. This can cause symptoms such as numbness and weakness. These may develop months or years after treatment. […] In some types of cancer, the body may make substances that damage peripheral nerves. This is called paraneoplastic syndrome. It may happen in people with lung cancer, myeloma or lymphoma.

• #95 Peripheral Neuropathy | Macmillan Cancer Support

  https://www.macmillan.org.uk/cancer-information-and-support/impacts-of-cancer/peripheral-neuropathy

  Different things can cause peripheral neuropathy, such as diabetes, injury, cancer and some cancer treatments. This information is about cancer-related causes of peripheral neuropathy. […] There are different ways that cancer and its treatments can cause peripheral neuropathy: […] Some anti-cancer drugs can cause nerve damage. This is the most common cause of peripheral neuropathy in people with cancer. […] Cancer can cause peripheral neuropathy in one area of the body if the tumour is growing close to a nerve and presses on it. […] Rarely, radiotherapy may damage nerves in the treated area. This can cause symptoms such as numbness and weakness. These may develop months or years after treatment. […] In some types of cancer, the body may make substances that damage peripheral nerves. This is called paraneoplastic syndrome. It may happen in people with lung cancer, myeloma or lymphoma.

• #96 Peripheral Neuropathy | Macmillan Cancer Support

  https://www.macmillan.org.uk/cancer-information-and-support/impacts-of-cancer/peripheral-neuropathy

  Different things can cause peripheral neuropathy, such as diabetes, injury, cancer and some cancer treatments. This information is about cancer-related causes of peripheral neuropathy. […] There are different ways that cancer and its treatments can cause peripheral neuropathy: […] Some anti-cancer drugs can cause nerve damage. This is the most common cause of peripheral neuropathy in people with cancer. […] Cancer can cause peripheral neuropathy in one area of the body if the tumour is growing close to a nerve and presses on it. […] Rarely, radiotherapy may damage nerves in the treated area. This can cause symptoms such as numbness and weakness. These may develop months or years after treatment. […] In some types of cancer, the body may make substances that damage peripheral nerves. This is called paraneoplastic syndrome. It may happen in people with lung cancer, myeloma or lymphoma.

• #97 Peripheral neuropathy in cancer patients | MD Anderson Cancer Center

  https://www.mdanderson.org/cancerwise/peripheral-neuropathy-in-cancer-patients.h00-158909334.html

  The nerve damage that causes peripheral neuropathy may be the result of many different factors, including some chemotherapy drugs using vinca alkaloids, platinum compounds, taxanes and thalidomide. […] Tumors themselves can cause nerve damage as well if they grow close to and press on the nerve. […] And, patients with cancers of the nervous system — such as brain tumors, spine tumors and skill base tumors — are more likely to develop peripheral neuropathy due to nerve damage resulting from the tumor.

• #98 Peripheral Neuropathy | Macmillan Cancer Support

  https://www.macmillan.org.uk/cancer-information-and-support/impacts-of-cancer/peripheral-neuropathy

  Different things can cause peripheral neuropathy, such as diabetes, injury, cancer and some cancer treatments. This information is about cancer-related causes of peripheral neuropathy. […] There are different ways that cancer and its treatments can cause peripheral neuropathy: […] Some anti-cancer drugs can cause nerve damage. This is the most common cause of peripheral neuropathy in people with cancer. […] Cancer can cause peripheral neuropathy in one area of the body if the tumour is growing close to a nerve and presses on it. […] Rarely, radiotherapy may damage nerves in the treated area. This can cause symptoms such as numbness and weakness. These may develop months or years after treatment. […] In some types of cancer, the body may make substances that damage peripheral nerves. This is called paraneoplastic syndrome. It may happen in people with lung cancer, myeloma or lymphoma.

• #99 Peripheral neuropathy in cancer patients | MD Anderson Cancer Center

  https://www.mdanderson.org/cancerwise/peripheral-neuropathy-in-cancer-patients.h00-158909334.html

  The nerve damage that causes peripheral neuropathy may be the result of many different factors, including some chemotherapy drugs using vinca alkaloids, platinum compounds, taxanes and thalidomide. […] Tumors themselves can cause nerve damage as well if they grow close to and press on the nerve. […] And, patients with cancers of the nervous system — such as brain tumors, spine tumors and skill base tumors — are more likely to develop peripheral neuropathy due to nerve damage resulting from the tumor.

• #100 Benign peripheral nerve tumor | Beacon Health System

  https://www.beaconhealthsystem.org/library/diseases-and-conditions/benign-peripheral-nerve-tumor?content_id=CON-20341913

  Several different types of tumors may form on the peripheral nerves. While some are caused by genetics, the cause of these tumors is usually not known. […] The cause of benign peripheral nerve tumors usually isn’t known. Some are passed down in families. […] For neurofibromas, having the genetic condition known as neurofibromatosis type 1 (NF1) is a risk factor. NF1 can cause someone to have several neurofibromas. But most people who have neurofibromas don’t have NF1. […] For schwannomas, having the gene that causes schwannomatosis is a risk factor.

• #101 Benign peripheral nerve tumor

  https://johnsonmemorial.org/jmh-health/disease-conditions/con-20341913

  Several different types of tumors may form on the peripheral nerves. The cause of these tumors is usually unknown. Some have a genetic cause. […] The cause of benign peripheral nerve tumors usually isn’t known. Some are passed down in families. […] The most common type of benign peripheral nerve tumor is a schwannoma. A schwannoma typically starts in a single bundle inside the main nerve, shifting the rest of the nerve. […] Another common type is a neurofibroma. A neurofibroma also often forms inside the nerve. Sometimes it grows from several nerve bundles. […] Perineuriomas are rare and can grow from inside or outside the nerve. Tumors outside a nerve can cause problems when they press on the nerve. Other benign tumors that form outside nerves are soft lumps of slow-growing fat cells called lipomas and ganglion cysts.

• #102

  https://journals.lww.com/jpat/fulltext/2022/26040/an_update_on_oral_peripheral_nerve_sheath_tumors.20.aspx

  Peripheral nerve sheath tumors (PNSTs) are defined as type of sarcomas that develops in cells which forms a protective sheath (covering) around the peripheral nerve, i.e., the cells of myelin sheath. […] Nerve tumors are of neuroectodermal in origin as it composed of small rounded ectodermal cells that mostly affect soft tissues. […] About 70% of nerve tumor occurrence is sporadic, but people with an inherited condition such as neurofibromatosis 1 and 2 and schwannomatosis (20%) have an increased risk of developing nerve sheath tumors. […] The majority of neurofibromas (90%) are sporadic and are caused by biallelic (double hit) inactivation of NF 1 gene on chromosomes 17q11.2. […] The minority of 10% are associated with germline mutations and about half of these are found in association with neurofibromatosis 2 (NF2) and the other half in association with schwannomatosis.

• #103 4 Signs of a Nerve Tumor: Anthony Echo, MD: Plastic Surgeon

  https://www.anthonyechomd.com/blog/4-signs-of-a-nerve-tumor

  Researchers arent clear about the cause of schwannomas as they typically appear in people who are otherwise healthy. In rare cases, schwannomas form as the result of a genetic disorder that causes multiple tumors. […] Schwannomas that cause problematic symptoms, like muscle weakness, loss of sensation, pain, or loss of function, may require excision through peripheral nerve surgery.

• #104 Nerve Sheath Tumor in Dogs | PetMD

  https://www.petmd.com/dog/conditions/neurological/c_multi_schwannoma

  Schwannomas are tumors that originate in the myelin sheath. […] Peripheral nerve sheath tumor is the term that has been proposed to include schwannomas, neurofibromas (nerve fiber tumors), neurofibrosarcomas (malignant nerve fiber tumors), and hemangiopericytoma (tumor of blood vessels and soft tissue), since they are all believed to arise from the same cell type. […] Causes: Idiopathic (unknown).

• #105 Nerve Sheath Tumor in Dogs

  https://www.dogcancer.com/articles/types-of-dog-cancer/nerve-sheath-tumor-in-dogs/

  Peripheral nerve sheath tumors grow from the cells that surround the peripheral nerves in your dog’s body. […] There is no known specific cause for canine peripheral nerve sheath tumors. Like all cancers, this is a multifactorial disease, which means that many things have to go wrong for it to occur. […] There are no known specific risk factors for peripheral nerve sheath tumors in dogs. […] In humans, exposure to radiation therapy and genetics may increase the risk of peripheral nerve sheath tumors, but we do not know if this is the same in dogs. […] Unfortunately, there is no known way to prevent peripheral nerve sheath tumors in dogs.

• #106 Cauda equina malignant peripheral nerve sheath tumor presenting with subarachnoid hemorrhage: a case report | Neurocirugía (English edition)

  https://www.revistaneurocirugia.com/en-cauda-equina-malignant-peripheral-nerve-articulo-S2529849624000583

  The mainstay of treatment in MPNST is surgical resection. An aggressive resection provides local control and have been related with better outcomes. In cases involving extensive bone removal for complete tumoral resection, spinal fixation is necessary to mitigate the risk of postoperative deformity. Adjuvant radiotherapy has been recommended to improve local control. However, regardless of gross total resection and adjuvant radiotherapy, the reported 5-year survival rates vary from 16% to 44%. […] Lumbar intradural MPNST is a rare etiology. The diagnosis might be challenging and initially considered in youth and NF I patients. Even lumbar disc herniation can mimic its clinical presentation. SSAH is a surgical novel finding on MPNST.

Zobacz więcej